Yu Lu
About Yu Lu
Yu Lu is the Executive Director in mRNA Therapeutics at BeiGene in Shanghai, China, with extensive experience in developing mRNA therapeutics and a strong background in RNA biology and cancer research.
Title
Yu Lu is the Executive Director in mRNA Therapeutics at BeiGene, based in Shanghai, China. He has extensive experience in the development of mRNA therapeutics, particularly targeting neurodegenerative diseases.
Current Role at BeiGene
Yu Lu currently holds the position of Executive Director in mRNA Therapeutics at BeiGene, where he works in Shanghai, China. His expertise lies in the development of mRNA-based treatments designed to address neurodegenerative diseases. In this role, he leverages his deep knowledge of RNA biology to contribute to cutting-edge advancements in therapeutic solutions.
Academic Background
Yu Lu's academic journey began at Fudan University, where he earned a Bachelor of Science in Chemistry and a Master of Science in Analytical Chemistry. He then pursued a Doctor of Philosophy (Ph.D.) in Analytical Chemistry at the University of Washington. Additionally, Yu Lu worked as a Graduate Student at both the Institute for Systems Biology and the University of Washington, contributing to his solid foundation in analytical and biochemical sciences.
Previous Academic and Research Positions
Yu Lu served as an Assistant Professor in Biochemistry and Biomedical Sciences at McMaster University from 2016 to 2022. Prior to that, he undertook significant research projects as a Research Fellow at Dana-Farber Cancer Institute and a Postdoctoral Research Fellow at Harvard Medical School, both between 2006 and 2014. His research has substantially contributed to the understanding of RNA biology and cancer research.
Professional Experience
Over his career, Yu Lu has held various key roles including an Editor for Elsevier's 'Data in Brief' journal from 2015 to 2019, and a Research Scientist specializing in Proteomics at Moderna Therapeutics from 2014 to 2015. His early career also includes time as a Graduate Student at both the Institute for Systems Biology and the University of Washington from 2001 to 2006. His experience spans across several leading research institutions and companies in the field of biochemistry and biomedical sciences.
Technical Skills and Expertise
Yu Lu is proficient in advanced scientific techniques such as Flow Cytometry and Proteomics, essential for his research in biochemistry and mRNA therapeutics. His strong background in RNA biology has been instrumental in his contributions to cancer research. During his tenure at Moderna Therapeutics, he made significant contributions to the field of proteomics.